BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27188167)

  • 41. Granulocyte-macrophage colony-stimulating factor increases tumor growth and angiogenesis directly by promoting endothelial cell function and indirectly by enhancing the mobilization and recruitment of proangiogenic granulocytes.
    Zheng Q; Li X; Cheng X; Cui T; Zhuo Y; Ma W; Zhao X; Zhao P; Liu X; Feng W
    Tumour Biol; 2017 Feb; 39(2):1010428317692232. PubMed ID: 28240048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow.
    Vidal A; Zacharoulis S; Guo W; Shaffer D; Giancotti F; Bramley AH; de la Hoz C; Jensen KK; Kato D; MacDonald DD; Knowles J; Yeh N; Frohman LA; Rafii S; Lyden D; Koff A
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6890-5. PubMed ID: 15867156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression.
    Bhattacharyya S; Mitra D; Ray S; Biswas N; Banerjee S; Majumder B; Mustafi SM; Murmu N
    Microvasc Res; 2019 Jan; 121():52-62. PubMed ID: 30381268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.
    Burghoff S; Gong X; Viethen C; Jacoby C; Flögel U; Bongardt S; Schorr A; Hippe A; Homey B; Schrader J
    BMC Cancer; 2014 Dec; 14():898. PubMed ID: 25465225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
    Maciag PC; Seavey MM; Pan ZK; Ferrone S; Paterson Y
    Cancer Res; 2008 Oct; 68(19):8066-75. PubMed ID: 18829565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
    Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
    Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of adult bone marrow-derived stem cells in choroidal neovascularization.
    Sengupta N; Caballero S; Mames RN; Butler JM; Scott EW; Grant MB
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4908-13. PubMed ID: 14578416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
    Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
    Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
    Lu R; Kujawski M; Pan H; Shively JE
    Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Host-derived pericytes and Sca-1+ cells predominate in the MART-1- stroma fraction of experimentally induced melanoma.
    Treviño-Villarreal JH; Cotanche DA; Sepúlveda R; Bortoni ME; Manneberg O; Udagawa T; Rogers RA
    J Histochem Cytochem; 2011 Dec; 59(12):1060-75. PubMed ID: 22147606
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pilot study of differentiation of bone marrow derived mesenchymal stem cells into endothelial cells induced by B16 melanoma cells in vitro].
    Ni CS; Zhao N; Sun T; Zhao XL; Wang XH; Gu Q; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):402-7. PubMed ID: 19781348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs.
    Dwenger A; Rosenthal F; Machein M; Waller C; Spyridonidis A
    Stem Cells; 2004; 22(1):86-92. PubMed ID: 14688394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells.
    Sun T; Sun BC; Ni CS; Zhao XL; Wang XH; Qie S; Zhang DF; Gu Q; Qi H; Zhao N
    Cancer Lett; 2008 May; 263(1):35-43. PubMed ID: 18234417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High Mobility Group Box 1 Promotes Angiogenesis from Bone Marrow-derived Endothelial Progenitor Cells after Myocardial Infarction.
    Nakamura Y; Suzuki S; Shimizu T; Miyata M; Shishido T; Ikeda K; Saitoh S; Kubota I; Takeishi Y
    J Atheroscler Thromb; 2015; 22(6):570-81. PubMed ID: 25735431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.
    Patenaude A; Fuller M; Chang L; Wong F; Paliouras G; Shaw R; Kyle AH; Umlandt P; Baker JH; Diaz E; Tong J; Minchinton AI; Karsan A
    Cancer Res; 2014 May; 74(9):2402-11. PubMed ID: 24599126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.
    Jung SY; Choi JH; Kwon SM; Masuda H; Asahara T; Lee YM
    J Cell Biochem; 2012 May; 113(5):1478-87. PubMed ID: 22298358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy.
    Stagg J; Lejeune L; Paquin A; Galipeau J
    Hum Gene Ther; 2004 Jun; 15(6):597-608. PubMed ID: 15212718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone marrow mesenchymal stem cells suppress metastatic tumor development in mouse by modulating immune system.
    Zhang L; Su XS; Ye JS; Wang YY; Guan Z; Yin YF
    Stem Cell Res Ther; 2015 Mar; 6(1):45. PubMed ID: 25889932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.